New drug trial aims to protect kidneys in autoimmune diseases

NCT ID NCT05097989

Terminated Disease control Sponsor: Alexion Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested an investigational drug, ALXN2050, in adults with two serious kidney diseases: lupus nephritis and IgA nephropathy. The goal was to see if adding ALXN2050 to standard care could better reduce protein in the urine and protect long-term kidney function. The trial was terminated early, and results are being analyzed to determine if the treatment was effective and safe.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Huntsville, Alabama, 35805, United States
Research Site

Loma Linda, California, 92350, United States
Research Site

Northridge, California, 91324, United States
Research Site

Gainesville, Florida, 32603, United States
Research Site

Nampa, Idaho, 83687, United States
Research Site

Des Moines, Iowa, 50309, United States
Research Site

Kansas City, Missouri, 64111, United States
Research Site

Albuquerque, New Mexico, 87106, United States
Research Site

New York, New York, 10016, United States
Research Site

Houston, Texas, 77054, United States
Research Site

Ciudad de Buenos Aires, C1015ABO, Argentina
Research Site

Córdoba, 5000, Argentina
Research Site

La Plata, B1902COS, Argentina
Research Site

Rosario, S2000DEJ, Argentina
Research Site

Clayton, 3168, Australia
Research Site

Liverpool, 2170, Australia
Research Site

Nedlands, 6009, Australia
Research Site

Westmead, 2145, Australia
Research Site

Belo Horizonte, 30150-221, Brazil
Research Site

Curitiba, 80030-110, Brazil
Research Site

Juiz de Fora, 36010-570, Brazil
Research Site

Porto Alegre, 90035-003, Brazil
Research Site

Porto Alegre, 90480-000, Brazil
Research Site

Salvador, 40150-150, Brazil
Research Site

Guangzhou, 510080, China
Research Site

McKinney, 75069, China
Research Site

Shanghai, 200040, China
Research Site

Berlin, 10117, Germany
Research Site

Essen, 45122, Germany
Research Site

Mainz A. Rhein, 55131, Germany
Research Site

Mannheim, 68135, Germany
Research Site

Marburg, 30625, Germany
Research Site

München, 81377, DE, Germany
Research Site

Ashkelon, 78306, Israel
Research Site

Haifa, 3109601, Israel
Research Site

Petah Tikva, 4941492, Israel
Research Site

Ramat Gan, 52621, Israel
Research Site

Bari, 70124, Italy
Research Site

Brescia, 25123, Italy
Research Site

Milan, 20132, Italy
Research Site

Naples, 80131, Italy
Research Site

Torino, 10154, Italy
Research Site

Guadalajara, 44140, Mexico
Research Site

México, 11570, Mexico
Research Site

Torreón, 27000, Mexico
Research Site

Niš, 18000, Serbia
Research Site

Novi Sad, 21000, Serbia
Research Site

Busan, 49241, South Korea
Research Site

Goyang-si, 10380, South Korea
Research Site

Seoul, 03080, South Korea
Research Site

Barcelona, 08025, Spain
Research Site

Barcelona, 8003, Spain
Research Site

Córdoba, 14004, Spain
Research Site

Girona, 17007, Spain
Research Site

L'Hospitalet de Llobregat, 08907, Spain
Research Site

Palma de Mallorca, 07120, Spain
Research Site

Seville, 41013, Spain
Research Site

Valencia, 46026, Spain
Research Site

Kaohsiung City, 833, Taiwan
Research Site

New Taipei City, 220, Taiwan
Research Site

New Taipei City, 23561, Taiwan
Research Site

Taichung, 40705, Taiwan
Research Site

Bangkok, 10400, Thailand
Research Site

Istanbul, 34093, Turkey (Türkiye)
Research Site

Bristol, BS105NB, United Kingdom
Research Site

Cambridge, CB2 0QQ, United Kingdom
Research Site

Doncaster, DN2 5LT, United Kingdom
Research Site

Leicester, LE5 4PW, United Kingdom
Research Site

London, E1 1BB, United Kingdom
Research Site

London, SE5 9RS, United Kingdom
Research Site

Manchester, M13 9WL, United Kingdom

Conditions

Explore the condition pages connected to this study.

IGAN IMMUNOGLOBULIN A NEPHROPATHY LN LUPUS NEPHRITIS